Page last updated: 2024-08-24

glucose, (beta-d)-isomer and Colitis-Associated Cancer

glucose, (beta-d)-isomer has been researched along with Colitis-Associated Cancer in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Chen, YE; Guan, T; Hou, S; Liang, J; Liu, Y; Lu, Y; Shen, Q; Xu, S; Zhu, S1
Duan, YQ; Li, Z; Luo, YP; Ma, XM; Si, XL; Song, BN; Wang, Y; Yang, QX; Zhang, Y; Zhang, YY1

Other Studies

2 other study(ies) available for glucose, (beta-d)-isomer and Colitis-Associated Cancer

ArticleYear
Asperuloside inhibited epithelial-mesenchymal transition in colitis associated cancer via activation of vitamin D receptor.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2022, Volume: 101

    Topics: Animals; Colitis-Associated Neoplasms; Cyclopentane Monoterpenes; Epithelial-Mesenchymal Transition; Glucosides; Lipopolysaccharides; Mice; NF-kappa B; Pyrans; Receptors, Calcitriol; RNA, Messenger; Transforming Growth Factor beta1

2022
Potential Chemoprevention of Paeoniflorin in Colitis-Associated Colorectal Cancer by Network Pharmacology, Molecular Docking, and In Vivo Experiment.
    Chemistry & biodiversity, 2022, Volume: 19, Issue:8

    Topics: Animals; Cell Transformation, Neoplastic; Chemoprevention; Colitis-Associated Neoplasms; Colorectal Neoplasms; Disease Models, Animal; Glucosides; Interleukin-6; Mice; Molecular Docking Simulation; Monoterpenes; Network Pharmacology; STAT3 Transcription Factor

2022
chemdatabank.com